Lauren Wallner was appointed to the faculty of General Medicine and joined CanSORT on April 1, 2014. Dr. Wallner returned to UM after finishing her PhD in Epidemiology at the School of Public Health in 2010. She was most recently employed at Kaiser Permanente Southern California and UCLA via a dually-mentored, post-doctoral research fellowship. Dr. Wallner is a cancer epidemiologist specializing in quality of care and quality of life issues in those with malignant conditions. She is a member of the P01 program “The Challenge of Individualizing Treatments for Patients with Breast Cancer” focused on building the program’s research initiative on primary care coordination in cancer care. She will also lead efforts on use of natural language processing to mine pathology reports and other clinical records for research. Dr. Wallner also conducts research activities related to risk, detection, and disparities in prostate cancer. She is currently developing interventions to improve cancer care coordination.
Video profile provided by LabTV
Wallner LP, Wang R, Jacobsen SJ, Haque R. Androgen deprivation therapy for treatment of localized prostate cancer and risk of second primary malignancies. Cancer Epidemiol Biomarkers Prev 2013; 22(2):313-316
Wallner LP, Jacobsen SJ.Prostate specific antigen and prostate cancer mortality: A systematic review. Am J Prev Med 2013; 45(3):318-26
Wallner LP, Frencher SK, Hsu JY, Chao CR, Nichol MB, Loo RK, Jacobsen SJ. Changes in Serum Prostate Specific Antigen Levels and the Identification of Prostate Cancer in a Large Managed Care Population. BJU Int 2013; 111(8):1245-52
Wallner LP, Morgenstern H, McGree ME, Jacobson DJ, St Sauver JL, Jacobsen SJ, Sarma AV. The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study. BJU Int 2011; 107(6):929-35